Rojo Todo, Federico Gustavo federico.rojo@uam.es
Actividades
- Artículos 181
- Libros 0
- Capítulos de libro 0
- Congresos 20
- Documentos de trabajo 0
- Informes técnicos 1
- Proyectos de investigación 0
- Tesis dirigidas 6
- Patentes o licencias de software 0
FOXC1 expression predicts capecitabine efficacy in triple-negative breast cancer patients from the GEICAM_CIBOMA trial.
- Rojo F
- Taylor CR
- Barrios C
- Torrecillas L
- Ruiz-Borrego M
- Perez-Buira S
- Bines J
- Guerrero-Zotano A
- Garcia-Saenz JA
- Torres R
- de la Haba-Rodriguez J
- Ayala F
- Gomez H
- Llombart A
- Rodriguez de la Borbolla M
- Baena-Cañada JM
- Barnadas A
- Calvo L
- Herranz J
- Rincon R
- Caballero R
- Bermejo B
- Ray PS
- Martín M
Clinical cancer research : an official journal of the American Association for Cancer Research - 26/6/2025
- ISSN 15573265
- iMarina
Adaptive Proteomic Changes in Protein Metabolism and Mitochondrial Alterations Associated with Resistance to Trastuzumab and Pertuzumab Therapy in HER2-Positive Breast Cancer
- Madoz-Gurpide, Juan
- Serrano-Lopez, Juana
- Sanz-alvarez, Marta
- Morales-Gallego, Miriam
- Rodriguez-Pinilla, Socorro Maria
- Rovira, Ana
- Albanell, Joan
- Rojo, Federico
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1/2/2025
- ISSN 14220067
- iMarina
Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells
- Oltra, Sara S
- Colomo, Sara
- Sin, Laura
- Perez-Lopez, Maria
- Lazaro, Sara
- Molina-Crespo, Angela
- Choi, Kyoung-Han
- Ros-Pardo, David
- Martinez, Lidia
- Morales, Saleta
- Gonzalez-Paramos, Cristina
- Orantes, Alba
- Soriano, Mario
- Hernandez, Alberto
- Lluch, Ana
- Rojo, Federico
- Albanell, Joan
- Gomez-Puertas, Paulino
- Ko, Jae-Kyun
- Sarrio, David
- Moreno-Bueno, Gema
Cell Death And Differentiation (p. 1366-1381) - 1/5/2023
10.1038/s41418-023-01143-y Ver en origen
- ISSN 13509047
Triple negative PAM50 non-basal breast cancer subtype predicts benefit from extended adjuvant capecitabine
- Asleh K
- Lluch A
- Goytain A
- Barrios C
- Wang XQ
- Torrecillas L
- Gao D
- Ruiz-Borrego M
- Leung S
- Bines J
- Guerrero-Zotano Á
- García-Sáenz JÁ
- Cejalvo JM
- Herranz J
- Torres R
- Haba-Rodriguez J
- Ayala F
- Gómez H
- Rojo F
- Nielsen TO
- Martin M
Clinical Cancer Research (p. 389-400) - 17/1/2023
- ISSN 15573265
- iMarina
The SMAD3-induced effects in colorectal cancer are orchestrated by a complex network of long noncoding RNAs
- Cristóbal I, Santos A, Rojo F, García-Foncillas J
Journal Of Cellular Physiology (p. 3-4) - 1/1/2023
- ISSN 00219541
- iMarina
A complex microRNA regulatory network may control the HCP5/UTP3/c-Myc/VAMP3 signaling axis
- Cristóbal I
- Santos A
- Rojo F
- García-Foncillas J
MOLECULAR THERAPY (p. 922-923) - 1/1/2023
- ISSN 15250016
- iMarina
The PP2A pathway plays a crucial role in controlling cardiac physiology
- Cristóbal I, Santos A, Rojo F, García-Foncillas J
American Journal Of Physiology-Heart And Circulatory Physiology (p. H65-H66) - 1/7/2022
- ISSN 15221539
- iMarina
Real-world biomarker testing rate and positivity rate in NSCLC in Spain: Prospective Central Lung Cancer Biomarker Testing Registry (LungPath) from the Spanish Society of Pathology (SEAP)
- Salas, Clara
- Martin-Lopez, Javier
- Martinez-Pozo, Antonio
- Hernandez-Iglesias, Teresa
- Carcedo, David
- Ruiz de Alda, Lucia
- Francisco Garcia, J
- Rojo, Federico
Journal Of Clinical Pathology (p. 193-200) - 1/3/2022
- ISSN 00219746
- iMarina
Molecular diagnosis in non-small-cell lung cancer: Expert opinion on ALK and ROS1 testing
- Conde, Esther
- Rojo, Federico
- Gomez, Javier
- Belen Enguita, Ana
- Abdulkader, Ihab
- Gonzalez, Ana
- Lozano, Dolores
- Mancheno, Nuria
- Salas, Clara
- Salido, Marta
- Salido-Ruiz, Eduardo
- de Alava, Enrique
Journal Of Clinical Pathology (p. 145-153) - 1/3/2022
10.1136/jclinpath-2021-207490 Ver en origen
- ISSN 00219746
mTOR inhibition and trastuzumab-emtansine (T-DM1) in HER2-positive breast cancer
- David Casadevall
- Anna Hernández‐Prat
- Sara García‐Alonso
- Oriol Arpí-Llucià
- Sílvia Menéndez
- Mengjuan Qin
- Cristina Guardia
- Beatriz Morancho
- Francisco Javier Sánchez-Martín
- Sandra Zazo
- Elena Gavilán
- Mohammad A. Sabbaghi
- Pîlar Eroles
- Juan Miguel Cejalvo
- Aña Lluch
- Federico Rojo
- Atanasio Pandiella
- Ana Rovira
- Joan Albanell
MOLECULAR CANCER RESEARCH (p. 1108-1121) - 1/1/2022
- ISSN 15417786
- iMarina
Este/a investigador/a no tiene libros.
Este/a investigador/a no tiene capítulos de libro.
Analytical Validation of HRD Calculation Performed with the OncoDEEP Comprehensive Genomic Panel
- Lefevre, Simon
- Ruano, Yolanda
- Rodriguez Peralto, Jose Luis
- Rojo Todo, Federico
- Carvajal Garcia, Nerea
- Abdulkader Nallib, Ihab
- Sanchez Ares, Maria
- Hernandez Losa, Javier
- Sese Faustino, Marta
- Ashour Garrido, Karim
- Lienard, Maxime
- Hong, Jessie
- Elias, Marc
- Rodrigo Martinez, Ana Belen
- Felipo Benavent, Amelia
Journal Of Molecular Diagnostics (p. S44-S44) - 1/6/2024
- ISSN 15251578
- iMarina
Use of liquid biomarker thymidine kinase activity (TKa) to predict outcome and progression in patients with metastatic breast cancer (MBC) in the GEICAM/2014-12 FLIPPER trial
- Albanell, Joan
- Williams, Amy
- Teresa Martinez, Maria
- Ritzen, Hanna
- Paris, Lorena
- O'Connor, Miriam
- De la Cruz Merino, Luis
- Santaballa, Ana
- Martinez-Janez, Noelia
- Anton, Fernando Moreno
- Fernandez, Isaura
- Company, Jesus Alarcon
- Guerra, Juan Antonio
- Ruiz-Borrego, Manuel
- Morris, Patrick G
- Portela, Marta
- Herranz, Jesus
- Caballero, Rosalia
- Bergqvist, Mattias
- Rojo Todo, Federico Gustavo
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Evaluating Ki67 and Oncotype DX Breast Recurrence Score during neoadjuvant treatment with letrozole/abemaciclib or chemotherapy in patients with highly proliferative HR+/HER2-breast cancer participating in the GEICAM CARABELA trial
- Guerrero, Angel
- Martin, Miguel
- Eva Perez, Maria
- Ruiz-Borrego, Manuel
- Martinez-Janez, Noelia
- Ignacio Chacon, Jose
- Gil Gil, Miguel J
- Andres, Raquel
- Sanchez-Rovira, Pedro
- Del Barco, Sonia
- Bermejo, Begona
- Fernandez, Isaura
- Garcia, Elisa
- Hernando, Blanca
- De La Haba, Juan
- Herranz, Jesus
- Portela, Marta
- Caballero, Rosalia
- Rojo Todo, Federico Gustavo
- Alba Conejo, Emilio
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Relationship of adaptive subtyping and tumour heterogeneity of treatment response to neoadjuvant therapy in hormone receptor-positive HER2-negative early breast cancer: PENELOPE-B
- Denkert, Carsten
- Rachakonda, Krishna
- Filipits, Martin
- Weber, Karsten
- Marme, Frederik
- Untch, Michael
- Witkiewicz, Agnieszka K
- Im, Seock-Ah
- DeMichele, Angela
- Pehl, Anika
- Van' t Veer, Laura
- Jank, Paul
- Schem, Christian
- Fasching, Peter A
- Reimer, Toralf
- Knudsen, Erik S
- Liu, Yuan
- Todo, Federico Gustavo Rojo
- Turner, Nicholas C
- Loibl, Sibylle
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Comprehensive clinical characteristics and ctDNA mutational profile analysis of endocrine resistance/sensitivity to adjuvant ET therapy in luminal breast cancer from the GEICAM/2014-03_RegistEM registry
- Guerrero, Angel
- Alvarez, Isabel
- Antolin Novoa, Silvia
- Cruz Jurado, Josefina
- Rodriguez Sanchez, Cesar Augusto
- Martinez, Purificacion
- Falo, Catalina
- Hernandez-Sosa, Maria
- Margeli, Mireia
- Gonzalez Maeso, Iria
- Rodriguez-Lescure, Alvaro
- Marin Alcala, Maria
- Anton, Antonio
- Varela Ferreiro, Silvia
- Herranz, Jesus
- Caballero, Rosalia
- Fernandez Garcia, Daniel
- Tibau, Ariadna
- Cobo, Sara Lopez-Tarruella
- Rojo Todo, Federico Gustavo
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Non-basal subtype defined by FOXC1 expression as an independent predictor of capecitabine efficacy in the triple negative breast cancer GEICAM/2003-11_CIBOMA/2004-01 trial
- Todo, Federico Gustavo Rojo
- Taylor, Clive R
- Barrios, Carlos H, Sr
- Torrecillas, Laura
- Ruiz-Borrego, Manuel
- Bines, Jose
- Segalla, Jose G M
- Guerrero, Angel
- Garcia-Saenz, Jose A
- Torres, Roberto
- De La Haba, Juan
- Ayala, Francisco
- Gomez, Henry Leonidas
- Llombart, Antonio
- Herranz, Jesus
- Rincon, Raul
- Caballero, Rosalia
- Bermejo, Begona
- Ray, Partha S
- Martin, Miguel
Journal Of Clinical Oncology - 1/6/2024
- ISSN 0732183X
- iMarina
Cost-benefit analysis of ALK diagnosis in patients with non-small cell lung cancer in Spain
- Ortega Granados, A L
- Rojo Todo, F
- Alvarez Alvarez, R
- Majem Tarruella, M
- Ruiz de Alda Iparraguirre, L
- Garcia Verdes-Montenegro, J F
- Gordo Flores, R
- Gonzalez-Dominguez, A
- Ivanova Markova, Y
- Sanchez San Cristobal, R
Annals Of Oncology (p. S960-S960) - 21/9/2021
10.1016/j.annonc.2021.08.1809 Ver en origen
- ISSN 09237534
A prognostic signature based on two-miRNA and pathological data in early-stage HER2+breast cancer patients
- Adam Artigues, A
- Beltran, M A
- Carbonell-Asins, J A
- Zuniga, S
- Moragon, S
- Martinez, M T M
- Hernando Melia, C
- Burgues, O
- Rojo Todo, F
- Albanell Mestres, J
- Lluch-Hernandez, A
- Bermejo, B
- Eroles, P
- Cejalvo, J M
Annals Of Oncology (p. S442-S442) - 21/9/2021
10.1016/j.annonc.2021.08.476 Ver en origen
- ISSN 09237534
MicroRNAs-449 regulate doxorubicin response through ACSL4 modulation in TNBC
- Torres Ruiz, S
- Garrido Cano, I
- Cervera Vidal, R
- Hernando Melia, C
- Martinez, M T M
- Zazo, S
- Burgues, O
- Rojo Todo, F
- Bermejo, B
- Lluch-Hernandez, A
- Cejalvo Andujar, J M
- Eroles, P
- Tormo Martin, E
Annals Of Oncology (p. S494-S495) - 21/9/2021
10.1016/j.annonc.2021.08.582 Ver en origen
- ISSN 09237534
A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)
- Llombart-Cussac, Antonio
- Cortes, Javier
- Bellosillo Paricio, Beatriz
- Gil Gil, Miguel
- Curigliano, Giuseppe
- Manuel Perez-Garcia, Jose
- Comerma Blesa, Laura
- Ruiz Borrego, Manuel
- Espinosa, Enrique
- Calvo, Lourdes
- Bermejo, Begona
- Bellet, Meritxell
- Rojo Todo, Federico
- de la Haba, Juan
- Quiroga, Vanesa
- Minisini, Alessandro
- Santaballa, Ana
- Sampayo, Miguel
- Malfettone, Andrea
- Albanell, Joan
Cancer Research - 1/2/2021
- ISSN 00085472
- iMarina
Este/a investigador/a no tiene documentos de trabajo.
Palbociclib Rechallenge for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
- Albanell J, Pérez-García JM, Gil-Gil M, Curigliano G, Ruíz-Borrego M, Comerma L, Gibert J, Bellet M, Bermejo B, Calvo L, de la Haba J, Espinosa E, Minisini AM, Quiroga V, Santaballa Bertran A, Mina L, Bellosillo B, Rojo F, Menéndez S, Sampayo-Cordero M, Popa C, Malfettone A, Cortés J, Llombart-Cussac A
Clinical Cancer Research (p. 67-80) - 1/1/2022
- ISSN 15573265
- iMarina
Este/a investigador/a no tiene proyectos de investigación.
Identification of molecular mechanisms of acquired resistance to trastuzumab in HER2+ breast cancer
- Rojo Todo, Federico (Director)
- Madoz-Gurpide, Juan (Director)
- Moreno Bueno, Gema (Tutor) Doctorando: González Alonso, Paula
24/4/2019
- iMarina
ntegración en la rutina diagnóstica de la clasificación molecular de los tumores gliales
- Rojo Todo, Federico (Codirector)
- Fortes Alen, Jose Roman (Codirector) Doctorando: Daoud, Lina
9/3/2017
- iMarina
Mecanismos de resistencia primaria y adquirida a trastuzumab en cáncer de mama HER2 positivo
- Manzarbeitia Arambarri, Felix Daniel (Autor o Coautor)
- F (Director)
- Federico Rojo (Director) Doctorando: Sandra Zazo Hernández
1/1/2017
- iMarina
Fenotipos intrínsecos y resultados clínico-patológicos del tratamiento neoadyuvante en pacientes con cáncer de mama
- ROJO TODO, FEDERICO GUSTAVO (Director) Doctorando: Maria Dolors Sabadell Mercadal
1/1/2017
- iMarina
Activación de las vías HGF/MET e HIPPO como predictores de resistencia al tratamiento con anticuerpos anti-EGFR en pacientes con carcinoma escamoso de cabeza y cuello recurrente o metastásico
- ROJO TODO, FEDERICO GUSTAVO (Director) Doctorando: Luz María Martín Fragueiro
1/1/2017
- iMarina
Este/a investigador/a no tiene patentes o licencias de software.
Perfiles de investigador/a
-
ORCID
-
Scopus Author ID
-
Dialnet id